Dana-Farber and Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA.
Department of Ophthalmology, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Am J Med Genet A. 2020 Jul;182(7):1754-1760. doi: 10.1002/ajmg.a.61593. Epub 2020 Apr 15.
Shwachman-Diamond syndrome (SDS) is an autosomal recessive multisystem disorder characterized by exocrine pancreatic dysfunction, bone marrow failure, and leukemia predisposition. Approximately 90% of cases are due to biallelic mutations in the Shwachman-Bodian-Diamond (SBDS) gene. Additional phenotypic features variably associated with SDS include skeletal, neurologic, hepatic, cardiac, endocrine, and dental abnormalities. We report five subjects with SDS who developed a range of inflammatory manifestations. Three patients developed inflammatory eye conditions. Single cases of juvenile idiopathic arthritis, chronic recurrent multifocal osteomyelitis, and scleroderma were also noted. Clinical presentation and treatment responses are described. Proteomic analysis revealed increased inflammatory signatures in SDS subjects as compared to controls. Treatment of inflammatory manifestations in patients with SDS may be complicated by potential myelosuppressive toxicities of anti-rheumatic medications. Further research is needed to better understand the potential link between inflammatory disorders and SDS to inform effective treatment strategies.
Shwachman-Diamond 综合征(SDS)是一种常染色体隐性多系统疾病,其特征为外分泌胰腺功能障碍、骨髓衰竭和白血病易感性。大约 90%的病例归因于 Shwachman-Bodian-Diamond(SBDS)基因的双等位基因突变。与 SDS 相关的其他表型特征包括骨骼、神经、肝脏、心脏、内分泌和牙科异常。我们报告了 5 名 SDS 患者,他们出现了一系列炎症表现。3 名患者出现了眼部炎症性疾病。还注意到了单例幼年特发性关节炎、慢性复发性多灶性骨髓炎和硬皮病。描述了临床表现和治疗反应。蛋白质组学分析显示,与对照组相比,SDS 患者的炎症特征增加。由于抗风湿药物可能具有潜在的骨髓抑制毒性,SDS 患者的炎症表现的治疗可能会变得复杂。需要进一步研究以更好地了解炎症性疾病和 SDS 之间的潜在联系,从而为制定有效的治疗策略提供信息。